Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05617313 |
Title | Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Jeffrey Clarke |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Illinois Cancer Center | Chicago | Illinois | 60612 | United States | Details | |
Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
Karmanos Cancer Center (Wayne State University) | Detroit | Michigan | 48201 | United States | Details | |
Summit Health | Berkeley Heights | New Jersey | 07922 | United States | Details | |
Duke Cancer Institute | Durham | North Carolina | 27710 | United States | Details | |
University of Virginia Health System | Charlottesville | Virginia | 22908 | United States | Details |